SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-034341
Filing Date
2022-12-02
Accepted
2022-12-02 17:02:46
Documents
18
Period of Report
2022-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57266
2 ex3-1.htm EX-3.1 150924
3 ex3-2.htm EX-3.2 59364
4 ex10-1.htm EX-10.1 291537
5 ex10-2.htm EX-10.2 192242
6 ex10-3.htm EX-10.3 26850
7 ex99-1.htm EX-99.1 17925
  Complete submission text file 0001493152-22-034341.txt   1124964

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ghsi-20221129.xsd EX-101.SCH 3245
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ghsi-20221129_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ghsi-20221129_pre.xml EX-101.PRE 22371
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3841
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 221442855
SIC: 2834 Pharmaceutical Preparations